GLP-1 medications like semaglutide stimulate your insulin production after meals, which help lower blood sugar levels, slow the emptying of your stomach, and reduce your appetite
Case-control analysis of single-cell RNA-seq studies
10.1016/j.bcp.2021.114578 Biochem
Specifically, the FDA states that microdosing is not a regulated term and there is no clinical evidence from large-scale trials demonstrating the safety and effectiveness of GLP-1 microdosing for mild appetite control, weight management, or longevity
This makes it easier to meet your protein needs without requiring large portions
When used for weight loss, Semaglutide acts similarly to GLP-1 in the body, vital in regulating blood sugar levels and appetite